FINDEX Inc. Logo

FINDEX Inc.

3649.T

(2.8)
Stock Price

806,00 JPY

24.13% ROA

29.85% ROE

14.97x PER

Market Cap.

22.097.450.487,00 JPY

0% DER

1.86% Yield

24.02% NPM

FINDEX Inc. Stock Analysis

FINDEX Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

FINDEX Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (17.22%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

4 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

5 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

6 Buffet Intrinsic Value

The company's stock seems undervalued (6.012) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (5.65x) suggests it's overvalued, potentially making it an expensive investment.

8 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

FINDEX Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

FINDEX Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

FINDEX Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

FINDEX Inc. Revenue
Year Revenue Growth
2009 772.034.000
2010 1.144.771.000 32.56%
2011 1.543.160.000 25.82%
2012 1.987.789.000 22.37%
2013 2.382.635.000 16.57%
2014 2.863.916.000 16.8%
2015 2.951.922.000 2.98%
2016 3.288.025.000 10.22%
2017 3.311.714.000 0.72%
2018 3.603.344.000 8.09%
2019 4.281.539.000 15.84%
2020 4.004.859.000 -6.91%
2021 4.968.885.000 19.4%
2022 4.541.242.000 -9.42%
2023 4.900.388.000 7.33%
2023 5.191.735.000 5.61%
2024 4.323.772.000 -20.07%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

FINDEX Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2009 0
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 2.972.000 100%
2016 6.037.000 50.77%
2017 13.481.000 55.22%
2018 37.579.000 64.13%
2019 23.416.000 -60.48%
2020 43.318.000 45.94%
2021 27.069.000 -60.03%
2022 39.016.000 30.62%
2023 0 0%
2023 52.898.000 100%
2024 53.216.000 0.6%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

FINDEX Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2009 0
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

FINDEX Inc. EBITDA
Year EBITDA Growth
2009 216.601.000
2010 420.994.000 48.55%
2011 520.354.000 19.09%
2012 916.326.000 43.21%
2013 1.056.109.000 13.24%
2014 1.278.793.000 17.41%
2015 978.431.000 -30.7%
2016 1.073.375.000 8.85%
2017 923.797.000 -16.19%
2018 1.000.027.000 7.62%
2019 1.171.466.000 14.63%
2020 1.016.261.000 -15.27%
2021 1.252.529.000 18.86%
2022 1.311.116.000 4.47%
2023 1.622.580.000 19.2%
2023 1.754.315.000 7.51%
2024 600.848.000 -191.97%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

FINDEX Inc. Gross Profit
Year Gross Profit Growth
2009 440.627.000
2010 702.560.000 37.28%
2011 842.008.000 16.56%
2012 1.215.439.000 30.72%
2013 1.433.168.000 15.19%
2014 1.780.540.000 19.51%
2015 1.641.957.000 -8.44%
2016 1.953.541.000 15.95%
2017 1.894.206.000 -3.13%
2018 1.993.748.000 4.99%
2019 2.330.527.000 14.45%
2020 2.119.677.000 -9.95%
2021 2.556.655.000 17.09%
2022 2.722.846.000 6.1%
2023 3.408.052.000 20.11%
2023 3.329.476.000 -2.36%
2024 2.325.372.000 -43.18%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

FINDEX Inc. Net Profit
Year Net Profit Growth
2009 84.893.000
2010 193.087.000 56.03%
2011 221.961.000 13.01%
2012 431.877.000 48.61%
2013 517.836.000 16.6%
2014 630.071.000 17.81%
2015 441.399.000 -42.74%
2016 499.915.000 11.71%
2017 366.628.000 -36.35%
2018 398.015.000 7.89%
2019 499.249.000 20.28%
2020 430.457.000 -15.98%
2021 636.027.000 32.32%
2022 722.779.000 12%
2023 1.133.288.000 36.22%
2023 1.059.140.000 -7%
2024 233.544.000 -353.51%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

FINDEX Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2009 433
2010 10 -4711.11%
2011 9 0%
2012 17 43.75%
2013 20 15.79%
2014 24 20.83%
2015 17 -41.18%
2016 19 10.53%
2017 14 -35.71%
2018 15 6.67%
2019 20 21.05%
2020 17 -18.75%
2021 25 33.33%
2022 28 14.29%
2023 0 0%
2023 41 100%
2024 9 -355.56%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

FINDEX Inc. Free Cashflow
Year Free Cashflow Growth
2009 33.224.000
2010 135.961.000 75.56%
2011 -24.336.000 658.68%
2012 272.264.000 108.94%
2013 280.384.000 2.9%
2014 1.038.015.000 72.99%
2015 -134.869.000 869.65%
2016 793.617.000 116.99%
2017 209.969.000 -277.97%
2018 262.206.000 19.92%
2019 1.298.508.000 79.81%
2020 281.163.000 -361.83%
2021 481.045.000 41.55%
2022 380.448.000 -26.44%
2023 559.869.000 32.05%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

FINDEX Inc. Operating Cashflow
Year Operating Cashflow Growth
2009 116.549.000
2010 269.618.000 56.77%
2011 171.846.000 -56.9%
2012 550.568.000 68.79%
2013 556.521.000 1.07%
2014 1.281.728.000 56.58%
2015 126.962.000 -909.54%
2016 1.137.233.000 88.84%
2017 580.488.000 -95.91%
2018 597.524.000 2.85%
2019 1.670.010.000 64.22%
2020 542.550.000 -207.81%
2021 750.353.000 27.69%
2022 693.848.000 -8.14%
2023 842.844.000 17.68%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

FINDEX Inc. Capital Expenditure
Year Capital Expenditure Growth
2009 83.325.000
2010 133.657.000 37.66%
2011 196.182.000 31.87%
2012 278.304.000 29.51%
2013 276.137.000 -0.78%
2014 243.713.000 -13.3%
2015 261.831.000 6.92%
2016 343.616.000 23.8%
2017 370.519.000 7.26%
2018 335.318.000 -10.5%
2019 371.502.000 9.74%
2020 261.387.000 -42.13%
2021 269.308.000 2.94%
2022 313.400.000 14.07%
2023 282.975.000 -10.75%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

FINDEX Inc. Equity
Year Equity Growth
2009 212.401.000
2010 398.501.000 46.7%
2011 952.713.000 58.17%
2012 1.376.182.000 30.77%
2013 1.842.614.000 25.31%
2014 2.343.480.000 21.37%
2015 2.504.114.000 6.41%
2016 2.628.715.000 4.74%
2017 2.815.464.000 6.63%
2018 2.545.450.000 -10.61%
2019 2.842.569.000 10.45%
2020 3.073.284.000 7.51%
2021 3.512.533.000 12.51%
2022 4.042.936.000 13.12%
2023 4.358.602.000 7.24%
2023 4.845.360.000 10.05%
2024 5.345.307.000 9.35%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

FINDEX Inc. Assets
Year Assets Growth
2009 564.710.000
2010 779.453.000 27.55%
2011 1.355.647.000 42.5%
2012 1.828.346.000 25.85%
2013 2.194.397.000 16.68%
2014 2.832.732.000 22.53%
2015 2.800.126.000 -1.16%
2016 3.102.542.000 9.75%
2017 3.324.021.000 6.66%
2018 3.114.829.000 -6.72%
2019 3.464.967.000 10.11%
2020 3.796.913.000 8.74%
2021 4.556.563.000 16.67%
2022 4.980.780.000 8.52%
2023 5.075.193.000 1.86%
2023 5.935.643.000 14.5%
2024 6.414.161.000 7.46%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

FINDEX Inc. Liabilities
Year Liabilities Growth
2009 352.309.000
2010 380.952.000 7.52%
2011 402.934.000 5.46%
2012 452.164.000 10.89%
2013 351.783.000 -28.53%
2014 489.252.000 28.1%
2015 296.012.000 -65.28%
2016 473.827.000 37.53%
2017 508.557.000 6.83%
2018 569.379.000 10.68%
2019 622.398.000 8.52%
2020 723.629.000 13.99%
2021 1.044.030.000 30.69%
2022 937.844.000 -11.32%
2023 716.591.000 -30.88%
2023 1.090.281.000 34.27%
2024 1.068.853.000 -2%

FINDEX Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
239.55
Net Income per Share
57.53
Price to Earning Ratio
14.97x
Price To Sales Ratio
3.59x
POCF Ratio
56.12
PFCF Ratio
56.12
Price to Book Ratio
4.14
EV to Sales
2.87
EV Over EBITDA
7.83
EV to Operating CashFlow
44.86
EV to FreeCashFlow
44.86
Earnings Yield
0.07
FreeCashFlow Yield
0.02
Market Cap
22,10 Bil.
Enterprise Value
17,66 Bil.
Graham Number
518.94
Graham NetNet
157.39

Income Statement Metrics

Net Income per Share
57.53
Income Quality
0.26
ROE
0.3
Return On Assets
0.23
Return On Capital Employed
0.36
Net Income per EBT
0.72
EBT Per Ebit
1.01
Ebit per Revenue
0.33
Effective Tax Rate
0.28

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.65
Operating Profit Margin
0.33
Pretax Profit Margin
0.33
Net Profit Margin
0.24

Dividends

Dividend Yield
0.02
Dividend Yield %
1.86
Payout Ratio
0
Dividend Per Share
16

Operating Metrics

Operating Cashflow per Share
15.34
Free CashFlow per Share
15.34
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.27
Return on Tangible Assets
0.24
Days Sales Outstanding
43.66
Days Payables Outstanding
1.85
Days of Inventory on Hand
40.63
Receivables Turnover
8.36
Payables Turnover
197.12
Inventory Turnover
8.98
Capex per Share
0

Balance Sheet

Cash per Share
172,82
Book Value per Share
208,27
Tangible Book Value per Share
196.74
Shareholders Equity per Share
208.03
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-1.97
Current Ratio
6.85
Tangible Asset Value
5,05 Bil.
Net Current Asset Value
4,40 Bil.
Invested Capital
5056263000
Working Capital
4,67 Bil.
Intangibles to Total Assets
0.05
Average Receivables
1,55 Bil.
Average Payables
0,08 Bil.
Average Inventory
271630000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

FINDEX Inc. Dividends
Year Dividends Growth
2011 3
2012 12 75%
2013 24 50%
2014 15 -60%
2015 4 -400%
2016 7 57.14%
2017 7 0%
2018 8 0%
2019 8 12.5%
2020 8 0%
2021 8 0%
2022 10 11.11%
2023 13 30.77%
2024 15 13.33%

FINDEX Inc. Profile

About FINDEX Inc.

FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.

CEO
Mr. Teruo Aibara
Employee
290
Address
Asahiseimei-Otemachi Building
Tokyo, 100-0004

FINDEX Inc. Executives & BODs

FINDEX Inc. Executives & BODs
# Name Age
1 Takashi Murakami
Executive Officer of Financial & Investor Relations
70
2 Mr. Koji Kondo
Medical Solutions Manager & Director
70
3 Mr. Hiroaki Hasegawa
Director of Consulting & Director
70
4 Mr. Chikara Miyagawa
Head of Package Development & Director
70
5 Mr. Teruo Aibara
Chief Executive Officer, President & Representative Director
70

FINDEX Inc. Competitors